Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X:
” Thanks to Binaytara Foundation, Heme Summit 2024 for the chance to speak about MPN-AP/BP!
-no standard approach to treatment and current strategies have limited utility
-clinical trials inclusive of MPN-AP/BP are desperately needed!
-we are looking to prospectively study IDHi and LSD1i.”
